MedPath

Aspen Pharmacare Canada Inc.

🇨🇦Canada
Ownership
-
Established
1850-01-01
Employees
-
Market Cap
$5.8B
Website
http://www.aspenpharma.com/

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

110

CANADA:55

Drug Approvals

ASPEN-DIENOGEST

Approval Date
Apr 14, 2020
CANADA

XYLOCAINE 0.5%

Approval Date
Oct 29, 2012
CANADA

XYLOCAINE 2% WITH EPINEPHRINE 1:200000

Approval Date
Apr 25, 2012
CANADA

XYLOCAINE 2%

Approval Date
Jan 29, 2009
CANADA

XYLOCAINE 1%

Approval Date
Jan 23, 2009
CANADA

ARIXTRA

Approval Date
Apr 17, 2008
CANADA

ARIXTRA

Approval Date
Apr 17, 2008
CANADA

ARIXTRA

Approval Date
Apr 17, 2008
CANADA

LINESSA 28

Approval Date
Jun 13, 2006
CANADA

LINESSA 21

Approval Date
Jun 13, 2006
CANADA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.